Results show CTCs could be ‘dynamic biomarkers in oncology’
CellBxHealth, the company specialising in circulating tumour cell (CTC) solutions, has presented encouraging results on cell visualisation and biomarker analysis, which could shape antibody-drug conjugate (ADC) therapy. The results, presented at the World ADC conference in San Diego, US, demonstrate successful cell visualisation and biomarker analysis across ADC targets… Read More
